Prohibits investment by State of pension and annuity funds in Chinese pharmaceutical companies.

This bill prohibits New Jersey's state pension and annuity funds from investing in Chinese pharmaceutical companies or any companies with business ties to them. It defines "Chinese pharmaceutical company" as entities with over 51% ownership by China's government, citizens, or civilian-run enterprises. Funds must divest from such investments within three years of the law's effective date, with annual reports tracking progress to the legislature. The law aims to redirect state investment toward New Jersey-based pharmaceutical manufacturing.